About Dr. Ravella Venkateswara Rao
Dr. Ravella Venkateswara Rao is a highly distinguished and widely respected Senior Consultant Medical Oncologist in Hyderabad. With over 46 years of comprehensive medical experience, including more than 28 years dedicated to specialised oncology services, he brings a wealth of knowledge to his practice. Dr. Rao holds the unique distinction of being the first qualified Medical Oncologist and the first trained Haematologist in the states of Andhra Pradesh and Telangana. His expertise encompasses a broad spectrum of cancer care, including chemotherapy, immunotherapy, management of solid organ malignancies (such as Lung, Breast, GIT, Prostate), and Haemato-Oncology. Dr. Rao is an active member of prestigious organisations like the Indian Society of Oncology (ISO) and the American Society of Clinical Oncology (ASCO), reflecting his commitment to global standards in cancer care. Renowned for his meticulous diagnostic approach and empathetic patient care, he is highly recommended by numerous patients.
- MBBS: Gandhi Medical College, Hyderabad (1979)
- MD (Internal Medicine): PGIMER, Chandigarh (1983)
- DM (Medical Oncology): Adyar Cancer Institute, Chennai (1990)
- Haematology Trainings
- Registered with Hyderabad Medical Council (Registration No. 8416 HMC)
- Solid Organ Malignancies (Lung, Breast, Gastrointestinal Tract, Prostate)
- Haematological Malignancies (Leukaemia, Lymphoma)
- Metastatic Tumours
- Bladder Cancer
- Bone Cancer
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Skin Cancer
- Stomach Cancer
- Testicular Cancer
- Thyroid Cancer
- Uterine Cancers
- Medical Oncology
- Haemato-Oncology
- Immuno-Oncology
- Chemotherapy administration (including complex regimens)
- Immunotherapy
- Targeted Therapy
- Pleural Fluid & Ascites draining
- Lumbar Puncture
- HIPEC (Hyperthermic Intraperitoneal Chemotherapy) & PIPAC (Pressurised Intraperitoneal Aerosol Chemotherapy)
- Transarterial Chemoembolization (TACE)
- Senior Consultant – KIMS Hospital, Secunderabad (Current)
- Consultant – Vivekananda Multispeciality Hospital, Begumpet (Concurrent)
- Consultant – Sindhu Hospital, Serilingampalle (Concurrent)
- Actively participated in research work and various workshops within the Medical Oncology field.
- Published numerous papers.
- Consistent participation in national and international haematology trainings and cancer conferences to stay updated with latest advancements.
- Pioneer Oncologist: Recognised as the first qualified Medical Oncologist in Andhra Pradesh & Telangana.
- Pioneer Haematologist: Acknowledged as the first trained Haematologist in Andhra Pradesh & Telangana.
- Extensive experience in handling complex medical oncology cases.
- Known for commitment to providing the best possible medical care with accuracy and empathy.
Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
Chemotherapy (per cycle) | ₹ 30,000 – ₹ 1,50,000+ | $ 500 – $ 700+ |
Immunotherapy (per cycle) | ₹ 1,50,000 – ₹ 4,00,000+ | $ 1,000 – $ 3,000+ |
Targeted Therapy (monthly cost) | ₹ 50,000 – ₹ 2,50,000+ | $ 600 – $ 3,000+ |
- Language Support: Dr. Rao is proficient in English. Cancer Rounds provides additional language support services for international patients as needed.
- Visa & Travel Assistance: Cancer Rounds assists international patients with medical visa invitation letters, travel arrangements, airport transfers, and finding suitable accommodation near the hospital.
- Pre-treatment Virtual Consultations: Cancer Rounds can facilitate remote second opinions or initial virtual consultations with Dr. Rao for international patients to review medical records and discuss treatment possibilities before travelling.
- Patient-Centred Care: Dr. Rao, best oncologist Hyderabad is deeply committed to providing the highest standard of medical care. His approach is marked by meticulous attention to accurate diagnosis and treating patients with empathy and respect throughout their cancer journey.
- Technology & Innovation: Dr. Rao incorporates modern treatment modalities like Immunotherapy and Targeted Therapy into his practice. His regular attendance at national and international conferences ensures he remains at the forefront of oncological advancements, offering patients evidence-based treatment options.